Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BMS To Sell ConvaTec Unit | Contract Pharma

What are you searching for?

Sign in
Breaking News

BMS To Sell ConvaTec Unit

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bristol-Myers Squibb is selling its therapy and surgical care unit, ConvaTec, to two private equity firms, Nordic Capital and Avista Capital Partners for $4.1 billion. The sale, expected to close in the third quarter, is part of the company’s strategy to shift its focus to biopharmaceuticals. This strategy also includes the sale of the company’s medical imaging unit for $525 million, as well as plans to sell between 10% and 20% of its Mead Johnson Nutritional unit.
   
“These decisions support our next-generation biopharma strategy,” said chairman and chief executive officer, James M. Cornelius. “We will now have additional financial resources to expedite that strategy as we continue to work to help patients prevail over serious diseases.”
   
In December, the company announced plans to lay off about 4,300 employees (10% of its work force) and close more than half of its manufacturing plants as part of its goal to save $1.5 billion annually by 2010.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters